Loading...
INNOTOX 50 units. is an innovative drug (botulinum toxin) type A developed by the South Korean company Medytox Inc.
 
This drug has gained great popularity in clinics in South Korea and Japan due to several advantages:
 
1) Structure of the drug: Innotox is available in a new liquid phase, so it does not require dilution. One bottle contains a ready-made product solution for 50 units.
 
2) Composition: the improved formula of the preparation does not contain: proteins, albumin, gelatin, compared with other similar drugs.
 
3) Temperature conditions: insensitive to temperature extremes, in contrast to solid-phase preparations. However, it is recommended that you keep it in the refrigerator until use. The opened bottle can be stored in the refrigerator at a temperature of 2 to 8 degrees 72 hours.
 
4) Diffusion: has the least diffusion among all botulinum toxins currently known.
 
5) Effect: during the course of procedures, the effect lasts up to 8 months, in contrast to other botulinum toxins, in which the effect lasts up to 4 months.
 
The active components are: botulinum toxin type A, L-methionine, polysorbate 20, buffered saline phosphate pH 7.0.
 
Indications
– blepharospasm;
– hemifacial spasm;
– cervical dystonia (spastic torticollis);
– focal spasticity of the wrist and hand in stroke patients;
– paralytic strabismus (squint);
– local muscle spasm in cerebral palsy in children aged 2 years and older;
– correction of facial wrinkles.
 
ACTIVE COMPONENTS
botulinum toxin type A,
L-methionine,
polysorbate 20,
buffered saline phosphate pH 7.0.
 
CONTRAINDICATIONS, COMPLICATIONS, POSSIBLE SIDE EFFECTS:
 
hypersensitivity to the components of the composition;
pregnancy and lactation;
inflammatory processes on the skin in the target area;
bleeding disorders;
herpes, as well as any infectious and chronic systemic diseases in the acute stage;
fever;
diabetes;
oncological diseases;
pronounced hernial protrusions on the lower and upper eyelids;
myasthenia gravis (Myasthenia Gravis) – an autoimmune disease that causes chronic muscle fatigue syndrome;
age before 18 and after 65 years.
MODE OF APPLICATION
 
A solution of the finished product is injected with a 30G needle at the rate of 4 units per 0.1 ml (regardless of the volume of syringe used).
Injections of the drug should be carried out by a qualified doctor who has undergone a training course.

Specifications INNOTOX 50 units
Brand INNOTOX

Reviews

There are no reviews yet.

Be the first to review “INNOTOX 50 units”

Your email address will not be published.

error: Content is protected !!